NCT05415007 GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer
| NCT ID | NCT05415007 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2022-09-21 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2022-09-21 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to examine a psychotherapeutic and psycho-educational intervention offered in virtual settings to caregivers of youth with cancer. Human subjects must be used because they are the object of the intervention.
Eligibility Criteria
Inclusion and Exclusion Criteria: Parents Inclusion * Child (0-17yrs) with recent (\<12 mo) cancer diagnosis * Fluent in English * Consent to research Exclusion: * Lack of proficiency in written and spoken English * Parent is under age 18 * Active Suicidal Ideation * Child with cancer does not provide assent Inclusion and Exclusion Criteria: Children Inclusion: * Recent (\<12 mo) cancer diagnosis in child * 8-17 Years old * Provides assent to participate in the study Exclusion: * Cannot read English * Parent is not enrolled in the study Anyone who is not a caregiver of children who have been diagnosed with cancer within the past 12 months will be excluded.
Contact & Investigator
Victoria E. Cosgrove, PhD
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT05415007 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 18 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05415007 currently recruiting?
Yes, NCT05415007 is actively recruiting participants. Contact the research team at veileen@stanford.edu for enrollment information.
Where is the NCT05415007 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT05415007 clinical trial?
NCT05415007 is sponsored by Stanford University. The principal investigator is Victoria E. Cosgrove, PhD at Stanford University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.